SIGNATURE2025-01-012025-03-31SIGNATURE2025-03-31SIGNATURE2024-03-31SIGNATURE2024-04-012025-03-31SIGNATURE2025-01-012025-03-31in-capmkt:OtherExpenses1MemberSIGNATURE2025-01-012025-03-31in-capmkt:OtherExpenses2MemberSIGNATURE2025-01-012025-03-31in-capmkt:OtherExpenses3MemberSIGNATURE2024-04-012025-03-31in-capmkt:OtherExpenses1MemberSIGNATURE2024-04-012025-03-31in-capmkt:OtherExpenses2MemberSIGNATURE2024-04-012025-03-31in-capmkt:OtherExpenses3MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2024-04-012025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2024-04-012025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2024-04-012025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2024-04-012025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2024-04-012025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2024-04-012025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2025-03-31in-capmkt:ReportableSegments1MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2025-03-31in-capmkt:ReportableSegments2MemberSIGNATURE2025-01-012025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2025-03-31in-capmkt:ReportableSegments3MemberSIGNATURE2025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1SIGNATURE2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1SIGNATURE2025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543990SIGNATURENOTLISTEDINE903U01023Signatureglobal (India) LimitedMain BoardEquity2024-04-012025-03-312025-05-152025-05-08INRMillionsQuarterlyFourth quarterMulti segment2025-05-1516:48:002025-05-1519:00:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated5204330000500010000570434000032145200003580000048298000012955000078790000106769000049771100007272300000727230000346700008130000011597000006112600000000611260000-193000060933000061095000031000060902000031000014051000014.344.34004.344.341. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), this Statement of Consolidated Financial Results for the quarter and year ended 31 March 2025 (Consolidated Financial Results) of Signatureglobal (India) Limited (the Holding Company or the Company) and its subsidiaries (the Company along with subsidiaries together referred to as the Group) has been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 15 May 2025 and have been subject to audit by the statutory auditors of the Company. <BR> <BR> 2. The Consolidated Financial Results, for the quarter and year ended 31 March 2025 have been prepared in accordance with the recognition and measurement principles of Indian Accounting Standards 34 Interim Financial Reporting (Ind AS - 34) prescribed under Section 133 of the Companies Act, 2013 (the Act) and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). <BR> <BR> 3. During the year ended 31 March 2024, the Company had completed its Initial Public Offer of 18961038 Equity shares having face value of Rs. 1 each at an issue price of Rs 385 per equity share (including share premium of Rs. 384 per share), comprising offer for sale of 3,298,701 shares by selling shareholder aggregating to Rs. 1270.00 million and a fresh issue of 15662337 shares aggregating to Rs. 6030.00 million. The equity shares of the Company were listed on BSE Limited and National Stock Exchange of India Limited on 27 September 2023. <BR> <BR> For detailed notes please refer financial results in pdf uploaded on stock excahnge.2024-04-012025-03-31AuditedConsolidated2498020000013997000002637990000019061880000776000001715310000514860000273830000375554000025329180000105072000001050720000450300000-411670000386300000101209000000001012090000-1003000010020600001010830000126000010008000001260000140510000171268300007.197.19007.197.19Impairment of Goodwill3150000Impairment Losses on Financial Assets10000Other Expenses1064530000Impairment of Goodwill4060000Impairment Losses on Financial Assets1760000Other Expenses374972000085126000040000003130800002495000026742000072000004420900004428100002116720000864240000488448000092797140000064430000012975320000200294000014605100006360100001771908000028722000012972380000123775820000128660300000140510000712683000072673400002906000072964000001545406000023416000015688220000355860000160440800008206200000128285000021797070000230799200001464530000327506500007245024000018590000100340000105319820000121363900000128660300000Real Estate5061460000NBFC19250000Others2557950000Real Estate24323630000NBFC74190000Others994635000076386600003434417000024343300009363970000520433000024980200000Real Estate1610700000NBFC19250000Others42090000Real Estate4339960000NBFC74190000Others1305700001672040000454472000012955000051486000081526000029791400007272300001050720000Real Estate117791240000NBFC667380000Others4223400001188809600009779340000128660300000Real Estate98370750000NBFC56900000Others479100009847556000022888340000121363900000514860000-15207780000-3021800000-4355670000-62030000011696000002046680000022467990000027383000010317000001284600003392500000009543200000-257870000000-48450000048029000005853620000000847070000050065500000000000062560000446830000235000000000000000000100451000012673300000008967700000-553530000456790000000000001397983000095755200007096000002926630000001406720000687006000006870060000610526000012975320000Remeasurement (loss)/ gain on defined benefit plans-2790000-2790000Remeasurement (loss)/ gain on defined benefit plans-13560000-13560000-860000-3530000-1930000-10030000AuditedtrueWalker Chandiok & Co LLPtrue2025-05-31